Antiretroviral Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 60 pages | ID: A28EF962BA1FEN
Market Monitor Global

Abstracts

Tire-derived fuel (TDF) is composed of shredded scrap tires.

This report contains market size and forecasts of Antiretroviral Drug in Global, including the following market information:

Global Antiretroviral Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Antiretroviral Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Multi-Class Drugs Combination Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antiretroviral Drug include Gilead Sciences, ViiV Healthcare, Bristol-Myer Squibb, AbbVie, Boehringer-Ingelheim, Johnson and Johnson, Merck and CIPLA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antiretroviral Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antiretroviral Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Antiretroviral Drug Market Segment Percentages, by Type, 2021 (%)

• Multi-Class Drugs Combination
• NRTI
• NNRTI
• Protease Inhibitors
• Other

Global Antiretroviral Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Antiretroviral Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Pharmaceutical Companies
• Other

Global Antiretroviral Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Antiretroviral Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antiretroviral Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Antiretroviral Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Gilead Sciences
• ViiV Healthcare
• Bristol-Myer Squibb
• AbbVie
• Boehringer-Ingelheim
• Johnson and Johnson
• Merck
• CIPLA

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antiretroviral Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antiretroviral Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIRETROVIRAL DRUG OVERALL MARKET SIZE

2.1 Global Antiretroviral Drug Market Size: 2021 VS 2028
2.2 Global Antiretroviral Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Antiretroviral Drug Players in Global Market
3.2 Top Global Antiretroviral Drug Companies Ranked by Revenue
3.3 Global Antiretroviral Drug Revenue by Companies
3.4 Top 3 and Top 5 Antiretroviral Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Antiretroviral Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antiretroviral Drug Players in Global Market
  3.6.1 List of Global Tier 1 Antiretroviral Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Antiretroviral Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Antiretroviral Drug Market Size Markets, 2021 & 2028
  4.1.2 Multi-Class Drugs Combination
  4.1.3 NRTI
  4.1.4 NNRTI
  4.1.5 Protease Inhibitors
  4.1.6 Other
4.2 By Type - Global Antiretroviral Drug Revenue & Forecasts
  4.2.1 By Type - Global Antiretroviral Drug Revenue, 2017-2022
  4.2.2 By Type - Global Antiretroviral Drug Revenue, 2023-2028
  4.2.3 By Type - Global Antiretroviral Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antiretroviral Drug Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Pharmaceutical Companies
  5.1.4 Other
5.2 By Application - Global Antiretroviral Drug Revenue & Forecasts
  5.2.1 By Application - Global Antiretroviral Drug Revenue, 2017-2022
  5.2.2 By Application - Global Antiretroviral Drug Revenue, 2023-2028
  5.2.3 By Application - Global Antiretroviral Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Antiretroviral Drug Market Size, 2021 & 2028
6.2 By Region - Global Antiretroviral Drug Revenue & Forecasts
  6.2.1 By Region - Global Antiretroviral Drug Revenue, 2017-2022
  6.2.2 By Region - Global Antiretroviral Drug Revenue, 2023-2028
  6.2.3 By Region - Global Antiretroviral Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Antiretroviral Drug Revenue, 2017-2028
  6.3.2 US Antiretroviral Drug Market Size, 2017-2028
  6.3.3 Canada Antiretroviral Drug Market Size, 2017-2028
  6.3.4 Mexico Antiretroviral Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Antiretroviral Drug Revenue, 2017-2028
  6.4.2 Germany Antiretroviral Drug Market Size, 2017-2028
  6.4.3 France Antiretroviral Drug Market Size, 2017-2028
  6.4.4 U.K. Antiretroviral Drug Market Size, 2017-2028
  6.4.5 Italy Antiretroviral Drug Market Size, 2017-2028
  6.4.6 Russia Antiretroviral Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Antiretroviral Drug Market Size, 2017-2028
  6.4.8 Benelux Antiretroviral Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Antiretroviral Drug Revenue, 2017-2028
  6.5.2 China Antiretroviral Drug Market Size, 2017-2028
  6.5.3 Japan Antiretroviral Drug Market Size, 2017-2028
  6.5.4 South Korea Antiretroviral Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Antiretroviral Drug Market Size, 2017-2028
  6.5.6 India Antiretroviral Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Antiretroviral Drug Revenue, 2017-2028
  6.6.2 Brazil Antiretroviral Drug Market Size, 2017-2028
  6.6.3 Argentina Antiretroviral Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Antiretroviral Drug Revenue, 2017-2028
  6.7.2 Turkey Antiretroviral Drug Market Size, 2017-2028
  6.7.3 Israel Antiretroviral Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Antiretroviral Drug Market Size, 2017-2028
  6.7.5 UAE Antiretroviral Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Gilead Sciences
  7.1.1 Gilead Sciences Corporate Summary
  7.1.2 Gilead Sciences Business Overview
  7.1.3 Gilead Sciences Antiretroviral Drug Major Product Offerings
  7.1.4 Gilead Sciences Antiretroviral Drug Revenue in Global Market (2017-2022)
  7.1.5 Gilead Sciences Key News
7.2 ViiV Healthcare
  7.2.1 ViiV Healthcare Corporate Summary
  7.2.2 ViiV Healthcare Business Overview
  7.2.3 ViiV Healthcare Antiretroviral Drug Major Product Offerings
  7.2.4 ViiV Healthcare Antiretroviral Drug Revenue in Global Market (2017-2022)
  7.2.5 ViiV Healthcare Key News
7.3 Bristol-Myer Squibb
  7.3.1 Bristol-Myer Squibb Corporate Summary
  7.3.2 Bristol-Myer Squibb Business Overview
  7.3.3 Bristol-Myer Squibb Antiretroviral Drug Major Product Offerings
  7.3.4 Bristol-Myer Squibb Antiretroviral Drug Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myer Squibb Key News
7.4 AbbVie
  7.4.1 AbbVie Corporate Summary
  7.4.2 AbbVie Business Overview
  7.4.3 AbbVie Antiretroviral Drug Major Product Offerings
  7.4.4 AbbVie Antiretroviral Drug Revenue in Global Market (2017-2022)
  7.4.5 AbbVie Key News
7.5 Boehringer-Ingelheim
  7.5.1 Boehringer-Ingelheim Corporate Summary
  7.5.2 Boehringer-Ingelheim Business Overview
  7.5.3 Boehringer-Ingelheim Antiretroviral Drug Major Product Offerings
  7.5.4 Boehringer-Ingelheim Antiretroviral Drug Revenue in Global Market (2017-2022)
  7.5.5 Boehringer-Ingelheim Key News
7.6 Johnson and Johnson
  7.6.1 Johnson and Johnson Corporate Summary
  7.6.2 Johnson and Johnson Business Overview
  7.6.3 Johnson and Johnson Antiretroviral Drug Major Product Offerings
  7.6.4 Johnson and Johnson Antiretroviral Drug Revenue in Global Market (2017-2022)
  7.6.5 Johnson and Johnson Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Antiretroviral Drug Major Product Offerings
  7.7.4 Merck Antiretroviral Drug Revenue in Global Market (2017-2022)
  7.7.5 Merck Key News
7.8 CIPLA
  7.8.1 CIPLA Corporate Summary
  7.8.2 CIPLA Business Overview
  7.8.3 CIPLA Antiretroviral Drug Major Product Offerings
  7.8.4 CIPLA Antiretroviral Drug Revenue in Global Market (2017-2022)
  7.8.5 CIPLA Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Antiretroviral Drug Market Opportunities & Trends in Global Market
Table 2. Antiretroviral Drug Market Drivers in Global Market
Table 3. Antiretroviral Drug Market Restraints in Global Market
Table 4. Key Players of Antiretroviral Drug in Global Market
Table 5. Top Antiretroviral Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Antiretroviral Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Antiretroviral Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Antiretroviral Drug Product Type
Table 9. List of Global Tier 1 Antiretroviral Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiretroviral Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antiretroviral Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Antiretroviral Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Antiretroviral Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Antiretroviral Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Antiretroviral Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Antiretroviral Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Antiretroviral Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Antiretroviral Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Antiretroviral Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Antiretroviral Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Antiretroviral Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Antiretroviral Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Antiretroviral Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Antiretroviral Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Antiretroviral Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Antiretroviral Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Antiretroviral Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Antiretroviral Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Antiretroviral Drug Revenue, (US$, Mn), 2023-2028
Table 30. Gilead Sciences Corporate Summary
Table 31. Gilead Sciences Antiretroviral Drug Product Offerings
Table 32. Gilead Sciences Antiretroviral Drug Revenue (US$, Mn), (2017-2022)
Table 33. ViiV Healthcare Corporate Summary
Table 34. ViiV Healthcare Antiretroviral Drug Product Offerings
Table 35. ViiV Healthcare Antiretroviral Drug Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myer Squibb Corporate Summary
Table 37. Bristol-Myer Squibb Antiretroviral Drug Product Offerings
Table 38. Bristol-Myer Squibb Antiretroviral Drug Revenue (US$, Mn), (2017-2022)
Table 39. AbbVie Corporate Summary
Table 40. AbbVie Antiretroviral Drug Product Offerings
Table 41. AbbVie Antiretroviral Drug Revenue (US$, Mn), (2017-2022)
Table 42. Boehringer-Ingelheim Corporate Summary
Table 43. Boehringer-Ingelheim Antiretroviral Drug Product Offerings
Table 44. Boehringer-Ingelheim Antiretroviral Drug Revenue (US$, Mn), (2017-2022)
Table 45. Johnson and Johnson Corporate Summary
Table 46. Johnson and Johnson Antiretroviral Drug Product Offerings
Table 47. Johnson and Johnson Antiretroviral Drug Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Antiretroviral Drug Product Offerings
Table 50. Merck Antiretroviral Drug Revenue (US$, Mn), (2017-2022)
Table 51. CIPLA Corporate Summary
Table 52. CIPLA Antiretroviral Drug Product Offerings
Table 53. CIPLA Antiretroviral Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Antiretroviral Drug Segment by Type in 2021
Figure 2. Antiretroviral Drug Segment by Application in 2021
Figure 3. Global Antiretroviral Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antiretroviral Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antiretroviral Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antiretroviral Drug Revenue in 2021
Figure 8. By Type - Global Antiretroviral Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Antiretroviral Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Antiretroviral Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Antiretroviral Drug Revenue Market Share, 2017-2028
Figure 12. US Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Antiretroviral Drug Revenue Market Share, 2017-2028
Figure 16. Germany Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Antiretroviral Drug Revenue Market Share, 2017-2028
Figure 24. China Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Antiretroviral Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Antiretroviral Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Gilead Sciences Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. ViiV Healthcare Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myer Squibb Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AbbVie Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Boehringer-Ingelheim Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson and Johnson Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. CIPLA Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)